Akut mieloid leukémia (AML): vizsgálatok itt: Dél-Korea

In Dél-Korea 16 Also abroad 761

16 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

1. fázisCsak meghívásos
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Where
Seoul
Életkor
18 év and over
People
120 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00
3. fázisTaking people
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Where
Daejeon, Goyang-si, Gyeonggi-do, Seoul
Életkor
18 év and over
People
600 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06852222 · EU 2024-520154-38-00
1/2. fázisTaking people
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Where
Seoul
Életkor
16 év and over
People
85 worldwide
Run by
AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00
2/3. fázisTaking people
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Where
Seongnam-si, Seoul
Életkor
18 év and over
People
660 worldwide
Run by
AbbVie
See details and how to joinNCT07581002 · EU 2025-523724-47-00
3. fázisTaking people
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Where
Busan, Daegu, Goyang-si, Seoul
Életkor
12 év and over
People
468 worldwide
Run by
Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00
3. fázisTaking people
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Where
Busan-si, Daegu, Daejeon, Hwasun, Namdong, Pusan, Seoul, Ulsan
Életkor
18 év and over
People
1300 worldwide
Run by
Kura Oncology, Inc.
See details and how to joinNCT07007312 · EU 2025-521314-25-00
1. fázisTaking people
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Where
Seoul
Életkor
6 hónap to 17 év
People
18 worldwide
Run by
AbbVie
See details and how to joinNCT07306832
2. fázisTaking people
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Where
Busan, Daegu, Goyang-si, Incheon, Jeonju, Seongnam, Seoul, Suwon, Ulsan
Életkor
18 év and over
People
130 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06824168
1/2. fázisTaking people
A Study of BGB-11417 in Participants With Myeloid Malignancies
Where
GangnamGu, SeodaemunGu
Életkor
18 év and over
People
260 worldwide
Run by
BeOne Medicines
See details and how to joinNCT04771130 · EU 2023-508881-14-00
No phaseTaking people
A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia
Where
Seoul
Életkor
19 év and over
People
165
Run by
Pfizer
See details and how to joinNCT05189639
1. fázisTaking people
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Where
Seoul
Életkor
18 év and over
People
260 worldwide
Run by
SillaJen, Inc.
See details and how to joinNCT05768932
1/2. fázisTaking people
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Where
Hwasun, Seoul
Életkor
12 év and over
People
606 worldwide
Run by
Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555
1. fázisTaking people
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
Where
Incheon, Seoul
Életkor
18 év and over
People
150 worldwide
Run by
Lomond Therapeutics Holdings, Inc.
See details and how to joinNCT06366789
1/2. fázisTaking people
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Where
Daegu, Pusan, Seongnam, Seoul
Életkor
18 év and over
People
240 worldwide
Run by
Aptose Biosciences Inc.
See details and how to joinNCT03850574 · EU 2023-503244-14-00
3. fázisCsak meghívásos
A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.
Where
Seoul
Életkor
15 év to 60 év
People
380
Run by
Asan Medical Center
See details and how to joinNCT03507842
No phaseTaking people
A Post-Marketing Surveillance Study to Assess the Safety of Oral Azacitidine Maintenance Therapy in Korean Patients With Acute Myeloid Leukemia
Where
Seoul
Életkor
19 év and over
People
154
Run by
Bristol-Myers Squibb
See details and how to joinNCT06073769